Table 2. Baseline characteristics and hormonal levels of participants in the bariatric surgery and control groups.
| Characteristic | Mean±SD | p-value | |
|---|---|---|---|
| Bariatric surgery group | Control group | ||
| Age (years) | 31.6±6.8 | 31.8±7.1 | 0.89 |
| BMI (kg/m) | 43.5±4.2 | 44.1±4.5 | 0.46 |
| FSH (mIU/mL) | 7.8±2.5 | 8.1±2.7 | 0.31 |
| LH (mIU/mL) | 5.2±1.8 | 5.3±1.9 | 0.72 |
| Estrogen (pg/mL) | 120.3±32.5 | 121.9±34.2 | 0.68 |
| Progesterone (ng/mL) | 1.1±0.4 | 1.2±0.4 | 0.17 |
| Leptin (ng/mL) | 32.5±9.3 | 32.8±9.7 | 0.83 |
| Adiponectin (μg/mL) | 8.7±2.1 | 8.6±2.2 | 0.72 |
| Endometriosis diagnosis (n) | 6 | 4 | 0.52 |
| PCOS (n)1) | 23 | 25 | 0.84 |
1)
PCOS and endometriosis are represented as the number of participants with each condition in each group and excluded from study before reaching to 174 individuals in both populations of bariatric surgery and control groups.
n, sample size.
BMI, body mass index; FSH, follicle-stimulating hormone; LH, luteinizing hormone; PCOS, polycystic ovary syndrome.